Newsletter | November 9, 2022

11.09.22 -- Insights To Help Ensure A Successful Clinical Trial

Investing In Up-Front Communication For An Effective Relationship

Dive into an excerpt of the CMO360° fall 2022 newsletter featuring insights and guidance from Joseph Arcangelo, co-founder and managing partner of the inSeption Group, about how CMOs can effectively engage with their outsourcing partners.

Clinical Research Considerations For Rare Disease Patients: Part 1 — Reinvigorate Patient Centricity

Rare disease protocol design, vendor selection, patient recruitment and retention, and site and patient qualification can be undermined by several factors. Learn why the clinical research community must use its influence to ensure trials are designed and executed in a way that considers each patient’s situation and overall well-being.

Gap Analysis And Collaboration Lead To Clinical Success

A comprehensive gap analysis examines documented procedures, SOPs, and QMS processes, but it also includes discussions with key personnel and scrutinizes outputs derived from these factors. Explore the “report card” — an independent key deliverable that helps the organization identify, prioritize, and remediate potentially problematic areas.

Site-Relationship Strategy: Ensuring Quality Data And Study Performance

Discover how effective site monitors drive the open communication, information-sharing, and mutual understanding of the other party’s challenges conducive to fruitful site relationships.

A Full-Service Outsourcing Partner With 97% Customer Retention

inSeption Group offers a full-service solution designed to disrupt the current outsourcing paradigm, resurrecting a common-sense approach to rebuild business trust and confidence in a client’s selected vendor. Primarily focused on oncology, hematology, neurodegenerative disorders, and rare/orphan disease indications, with a specialization in cell and gene therapy, inSeption has been a solution for those fatigued from the progressive degradation of today’s outsourcing options. Contact them.